VOLORIDGE INVESTMENT MANAGEMENT, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 196 filers reported holding SAGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,460,521
-65.8%
70,968
-46.3%
0.01%
-68.2%
Q2 2022$4,267,000
+190.1%
132,101
+197.3%
0.02%
+175.0%
Q1 2022$1,471,000
-74.2%
44,440
-66.9%
0.01%
-74.2%
Q4 2021$5,711,000
-46.3%
134,245
-44.1%
0.03%
-55.1%
Q3 2021$10,644,000
+27.9%
240,207
+63.9%
0.07%
+19.0%
Q2 2021$8,325,000
-33.4%
146,546
-12.3%
0.06%
-36.3%
Q1 2021$12,504,000
-17.3%
167,059
-4.4%
0.09%
-28.3%
Q4 2020$15,113,000
+49.6%
174,699
+5.7%
0.13%
+51.2%
Q3 2020$10,100,000
-30.1%
165,247
-52.4%
0.08%
-49.1%
Q2 2020$14,443,000
+146.8%
347,353
+70.5%
0.16%
-1.8%
Q1 2020$5,851,000
+389.6%
203,712
+1130.8%
0.17%
+630.4%
Q4 2019$1,195,000
-51.4%
16,551
-5.6%
0.02%
-46.5%
Q3 2019$2,458,000
-72.3%
17,524
-67.5%
0.04%
-77.8%
Q4 2017$8,879,000
+50.7%
53,908
-27.1%
0.19%
+32.0%
Q2 2017$5,890,000
-0.6%
73,953
-11.3%
0.15%
+2.1%
Q1 2017$5,924,000
+130.8%
83,353
+65.8%
0.14%
+161.8%
Q4 2016$2,567,00050,2660.06%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders